false statements

Stellantis faces securities class action over alleged false EV strategy claims; investors have until June 8, 2026 to join lawsuit.

Investors in $SLNO have until May 5, 2026 to join securities lawsuit alleging undisclosed safety issues with DCCR drug candidate.

Securities lawsuit filed against $PINS alleges false statements on ad revenue and tariff impacts. Eligible investors have until May 29, 2026 deadline.

Pomerantz LLP sues ODDITY Tech ($ODD) alleging executives concealed partner algorithm changes that inflated customer acquisition costs, leading to undisclosed 30% revenue decline and 49% stock crash.

Class action filed against Babcock & Wilcox alleging undisclosed conflicts in Applied Digital contract and overstated financial prospects. Securities holders from November 2025-March 2026 may be eligible.

Apollo Global Management faces class action lawsuit alleging executives falsely denied business dealings with Jeffrey Epstein. Investors from May 2021–February 2026 eligible to join.

ImmunityBio investors must act by May 26, 2026 to claim lead plaintiff status in securities fraud class action alleging executive misstatements about Anktiva drug capabilities.

Schall Law Firm recruits SES AI investors for securities fraud class action over alleged false statements regarding partnerships and Molecular Universe platform misrepresentations.

monday.com faces securities class action over alleged false growth statements. Investors have until May 11, 2026 to claim lead plaintiff status.

Rosen Law Firm recruits Medpace investors for class action alleging false backlog statements. Lead plaintiff deadline: June 8, 2026.

Class action lawsuit filed against $MDPC alleges false statements inflated share price. Investors who bought stock between April 2025 and February 2026 may be eligible.

Rosen Law Firm urges $UPST investors to join securities lawsuit alleging false statements about AI risk tool. Lead plaintiff deadline: June 8, 2026.

Rosen Law Firm urges investors in $LU, Upstart, and Trip.com to join securities class actions alleging false statements and financial misstatements before critical deadlines.

Soleno Therapeutics faces class action lawsuit alleging false safety disclosures about DCCR drug candidate for Prader-Willi syndrome.

Law firm files class action against Regencell Bioscience ($RGC) alleging false statements about market manipulation risks. Investors urged to join case by June 23, 2026 deadline.

Class action filed against $GO alleging securities fraud over false financial statements and unsustainable expansion strategy requiring major restructuring.

Class action lawsuit filed against $UPST alleging false statements about Model 22 AI underwriting capabilities and inflated performance metrics.

Class action lawsuit filed against Camping World Holdings alleging securities fraud over false inventory management statements and overstated consumer demand between April 2025 and February 2026.

Investors in $BSX have until May 4, 2026 to join securities class action alleging management concealed unsustainable growth and misled on segment performance.

Schall Law Firm investigates Elite Express Holding ($ETS) for alleged securities fraud involving false statements and failure to disclose material information to investors.